11/14/14: Blood Lead Teleform Implementation at the State Lab (PDF, 198 KB)
Blood lead testing is encouraged as an important element of a comprehensive program to eliminate childhood lead poisoning. The goal of such testing is to identify children who need individual interventions to reduce their exposure.
The Centers for Disease Control and Prevention (CDC) recommend a blood lead test be performed on all children at ages 1 and 2 years and on children ages 36-72 months who have not been screened previously. Lead has no known physiological value and children are particularly susceptible to its toxic effects. Most affected children have no apparent symptoms, and consequently, many cases go undiagnosed and untreated.
Direct blood lead measurement is the screening test of choice. Finger-stick, capillary blood specimens are adequate for the initial screening test, provided that precautions are taken to minimize the risk of contamination. Venous blood specimens should be collected for confirmation of all elevated blood lead results. The North Carolina State Laboratory of Public Health (N.C.SLPH) will analyze blood lead specimens for children less than six years of age and refugee children through 16 years of age. On average, the NCSLPH performs testing on > 100,000 specimens annually using ICP/MS (Inductively Couple Plasma Mass Spectometer) technology.
N.C.SLPH will not process blood lead specimens collected on patients who are not residents of North Carolina. If any serious elevations were detected, the North Carolina Childhood Lead Poisoning Prevention Program would not have any jurisdiction in another state.